Bio-UV Group SA

As of December 31, 2024, Bio-UV Group SA carries a market capitalization of 21.68M, placing it among publicly traded companies globally. Its enterprise value stands at 47.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bio-UV Group SA's next confirmed earnings release is scheduled for April 7, 2027.

As of December 31, 2024, Bio-UV Group SA has 10.03M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Bio-UV Group SA maintains a current ratio of 2.66, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Bio-UV Group SA's stock has declined approximately 43.44% over the past 52 weeks. The 50-day moving average sits at 1.20, while the 200-day moving average is 1.32.

As of December 31, 2024, Bio-UV Group SA holds 3.87M in cash and equivalents against 29.55M in total debt, resulting in a net debt position of 17.03M. Total book value stands at 32.69M, with working capital of 14.78M providing operational flexibility.

Bio-UV Group SA's most recent stock split took place on January 29, 2025.